- Webinar Speakers
Dr. Gerald Goh
Senior Regional Segment Marketing Manager
Illumina, Asia Pacific JapanDr. Gerald Goh has more than 10 years of research experience in using genetics to understand the biology and underlying mechanisms of various human diseases, from autism to cancer. His career in oncology research began with the use of exome sequencing for the identification of driver genes in a variety of human cancers, using some of the first whole-exome capture arrays to interrogate the mutational landscape in these cancers. His work with numerous key opinion leaders around the world has resulted in over 25 peer-reviewed publications in high-impact journals including Nature Genetics.
Prior to joining Illumina, Gerald was part of the business development team at the Genome Institute of Singapore, stimulating research collaborations and industry partnerships in oncology. His current focus is on driving momentum in next-generation sequencing applications across the cancer continuum, from basic research to clinical testing. Gerald received his PhD in Genetics from Yale University and holds a Bachelor of Arts degree in Biological Sciences from the University of Chicago.
- Webinar Abstract
With hundreds of biomarkers linked to approved drugs and ongoing clinical trials comes a need for consolidated testing in a single assay. Comprehensive Genomic Profiling (CGP) is a powerful assay that:
- enables simultaneous detection of 500+ oncology biomarkers in single, next-generation sequencing test.
- identifies actionable biomarkers that help optimize treatment. In a series of studies, up to 90% of patients had actionable alterations as a result of CGP testing.
- provides faster results using fewer samples for increased efficiency.
Watch this webinar with Dr Gerald Goh to learn how CGP is improving biomarker detection, leading to actionable insights and increased efficiencies.